Fatal Campylobacter jejuni bacteraemia in patients with AIDS

Journal of Medical Microbiology

Volumn 48, Issue 6, 1999, Pages 601-603

  Manfredi, Roberto ^b   Nanetti, Anna ^a   Ferri, Morena ^a   Chiodo, Francesco ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CAMPYLOBACTER JEJUNI; CASE REPORT; CLINICAL FEATURE; FECES CULTURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0032854264     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-6-601     Document Type: Article

References (25)

1. 1. Blaser MJ, Perez-Perez G, Smith PF et al. Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis 1986; 153: 552-559.
2. 2. Shandera WX, Tormey MP, Blaser MJ. An outbreak of bacteremic Campylobacter jejuni infection. Mt Sinai J Med 1992; 59: 53-56.
3. 3. Molina J.-M, Casin I, Hausfater P et al. Campylobacter infections in HIV-infected patients: clinical and bacteriological features. AIDS 1995; 9: 881 885.
4. 4. Tee W, Mijch A, Wright E, Yung A. Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus. Clin Infect Dis 1995; 21: 634-638.
5. 5. Sorvillo FJ, Lieb LE, Waterman SH. Incidence of campylobacteriosis among patients with AIDS in Los Angeles County. J Acquir Immune Defic Syndr 1991; 4: 598-602.
6. 6. Ruiz-Contreras J, Ramos JT, Hernandez-Sampelayo T et al. for the Madrid HIV Pediatric Infection Collaborative Study Group. Sepsis in children with human immunodeficiency virus infection. Pediatr Infect Dis J 1995; 14: 522-526.
7. 7. Bernard E, Carles M, Pradier C, Ozouf N, Dellamonica P. Septicémies communautaires et nosocomiales chez le patient infecté par le virus de l'immunodéficience humaine. [Community-acquired and nosocomial septicemias in patients with human immunodeficiency virus infection.] Presse Med 1996; 25: 746-750.
8. 8. Nelson MR, Shanson DC, Hawkins DA, Gazzard BG. Salmonella, Campylobacter, and Shigella in HIV-seroposive patients. AIDS 1992; 6: 1495-1498.
9. 9. Perlman DM, Ampel NM, Schifman RB et al. Persistent Campylobacter jejuni infections in patients infected with human immunodeficiency virus (HIV). Ann Intern Med 1988; 108; 540-546.
10. 10. Bernard E, Roger PM, Carles D, Bonaldi V, Fournier JP, Dellamonica P. Diarrhea and Campylobacter infections in patients infected with the human immunodeficiency virus. J. Infect Dis 1989; 159; 143-144.
11. 11. Costel EE, Wheeler AP, Gregg CR. Campylobacter fetus spp. fetus cholecystitis and relapsing bacteremia in a patient with acquired immunodeficiency syndrome. South Med J 1984; 77: 927-928.
12. 12. Wheeler AP, Gregg CR. Campylobacter bacteremia, cholyecystitis, and the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105: 804.
13. 13. Peterson MC, Farr RW, Castiglia M. Prosthetic hip infection and bacteremia due to Campylobacter jejuni in a patient with AIDS. Clin Infect Dis 1993; 16: 439-440.
14. 14. Pigrau C, Almirante B, Pahissa A, Bartolomé R. Campylobacter spp. bacteremia in AIDS patients. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12: 93-95.
15. 15. Mishu B, Blaser MJ. Campylobacter jejuni, human immunodeficiency virus, and the Guillain-Barré syndrome. J Infect Dis 1994; 169: 1177.
16. 16. Kemper CA, Mickelson P, Morton A, Walton B, Deresinski SC. Helicobacter (Campylobacter) fennelliae-like organisms as an important but occult cause of bacteremia in a patient with AIDS. J Infect 1993; 26: 97 101.
17. 17. Evans TG, Riley D. Campylobacter laridis colitis in a human immunodeficiency virus-positive patient treated with a quinolone. Clin Infect Dis 1992; 15: 172-173.
18. 18. Burman WJ, Cohn DL, Reves RR, Wilson ML. Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia. Clin Infect Dis 1995; 20: 564-570.
19. 19. Kiehlbauch JA, Tauxe RV, Baker CN, Wachsmuth IK. Helicobacter cinaedi-associated bacteremia and cellulitis in immunocompromised patients. Ann Intern Med 1994; 121: 90-93.
20. 20. Funke G, Baumann R, Penner JL, Altwegg M. Development of resistance to macrolide antibiotics in an AIDS patient treated with clarithromycin for Campylobacter jejuni diarrhea. Eur J Clin Microbiol Infect Dis 1994; 13: 612-615.
21. 21. Wang WLL, Blaser MJ. Detection of pathogenic Campylobacter species in blood culture systems J Clin Microbiol 1986; 23: 709-714.
22. 22. Krumholz HM, Sande MA, Lo B. Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am J Med 1989; 86: 776-779.
23. 23. Andiman WA, Mezger J, Shapiro E. Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1. J Pediatr 1994; 124: 846-852.
24. 24. Meyer CN, Skinhoj P, Prag J. Bacteremia in HIV-positive and AIDS patients; incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infect Dis 1994; 26: 635-642.
25. 25. Fichtenbaum CJ, Dunagan WC, Powderly WG. Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 51-57.